Fig. 1From: Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutationTreatment Choices With Denosumab-Like and a Tamoxifen-Like Medicines. a. Medicine 1, a Denosumab-Like Medicinea. b. Medicine 2, a Tamoxifen-Like Medicinea. a Illustration describes the choices used to elicit women’s preferences for breast cancer risk reductionBack to article page